| ID | 346 |
|---|
| No | 346 |
|---|
| Brand Name | CRIZOCARE |
|---|
| Ingredients | CRIZOTONIB 250 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 60'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FIRST LINE TREATMENT OF ADULTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE ADVANCED NON SMALL CELL LUNG CANCER, TREATMENT OF ADULTS WITH PREVIOUSLY TREATED ANAPLASTIC LYMPHOMA KINASE-POSITIVE ADVANCED NON SMALL CELL LUNG CANCER, TREATMENT OF ADULT WITH ROS1-POSITIVE ADVANCED NON SMALL CELL LUNG CANCER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | CAPSULE SIZE 0, RED CAPSULE CAP AND WHITE CAPSULE BODY |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 0847/21 |
|---|
| FDD Registration Date | 07/08/2024 |
|---|
| Expiry Date | 06/08/2027 |
|---|
